BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that Dr. Gabriel Sosne, Assistant Professor of Ophthalmology at Wayne State University School of Medicine and the Kresge Eye Institute in Detroit, MI, presented data from a study entitled, “Lipid Rafts and Actin Are Important for Thymosin Beta 4-Mediated Anti-Inflammatory Effects in the Cornea,” at the Association for Research in Vision and Ophthalmology (ARVO) in Ft. Lauderdale, FL. This work continues to define the anti-inflammatory mechanisms of Tß4 that have been reported by Dr. Sosne and others in numerous in vitro and in vivo studies in the eye, skin, and heart.
